ATTACH_ATTACH_Amendment_0001 (1).pdf

SPE2D2-21-R-0116 Amendment 0001 - Levalbuterol HCL Solution

Solicitation Page 35

Technical Requirements:

a. Tab A: Offeror's Signed & Completed SF 1449 and all pages of the solicitation (1 through 99).

b. Tab B: Trade Agreements

Offeror shall fill in the chart below, identifying the Country of Origin of all offered end products in accordance with DFARS 252.225-7020, Trade Agreements Certificate, and DFARS 252.225-7021, Trade Agreements (Currently subject to Class Deviation 2020-O0019), and also identifying the Country of Origin for all Active Pharmaceutical Ingredients (APIs).

Item Number and Description Trade Agreements Act (TAA)

Country of Origin of End Product

Country of Origin for active pharmaceutical ingredient (API)

0001 – Levalbuterol HCL 0.63MG/3ML Solution – 24 or 25 count case

0002 – Levalbuterol HCL 1.25MG/3ML Solution – 24 or 25

0003 – Levalbuterol HCL 0.31MG/3ML Solution – 24 or 25

Solicitation Page(s) 70 and 71

TABLETS, CAPSULES AND PILLS

Item Complete Address of Facility Where Ingredients are

Measured, Weighed, Mixed and Compounded

Point of Contact Including Phone Number

0001 – Levalbuterol HCL

0002 - Levalbuterol HCL

PACKAGING

Item Complete Address of Facilities Where

Intermediate Containers will be Filled and Labeled

Point of Contact Including Phone Number

0001 – Levalbuterol HCL

PACKING

Item Complete Address of Facilities Where Products will be Packed and Prepared for Shipment

Point of Contact Including Phone Number

0001 – Levalbuterol HCL